Optimizing tyrosine kinase inhibitor therapy in gastrointestinal stromal tumors: exploring the benefits of continuous kinase suppression.
about
PET-based molecular imaging in personalized oncology: potential of the assessment of therapeutic outcome.Anti-angiogenesis target therapy for advanced osteosarcoma (Review).Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.What is New in Gastrointestinal Stromal Tumor?
P2860
Optimizing tyrosine kinase inhibitor therapy in gastrointestinal stromal tumors: exploring the benefits of continuous kinase suppression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Optimizing tyrosine kinase inh ...... continuous kinase suppression.
@en
Optimizing tyrosine kinase inh ...... continuous kinase suppression.
@nl
type
label
Optimizing tyrosine kinase inh ...... continuous kinase suppression.
@en
Optimizing tyrosine kinase inh ...... continuous kinase suppression.
@nl
prefLabel
Optimizing tyrosine kinase inh ...... continuous kinase suppression.
@en
Optimizing tyrosine kinase inh ...... continuous kinase suppression.
@nl
P2860
P50
P1433
P1476
Optimizing tyrosine kinase inh ...... continuous kinase suppression.
@en
P2093
Peter Reichardt
P2860
P304
P356
10.1634/THEONCOLOGIST.2012-0361
P577
2013-10-17T00:00:00Z